DGHMC
ELOS

Dalton, Greiner, Hartman, Maher & Co’s Syneron Medical Ltd ELOS Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-879,740
Closed -$9.63M – 191
2017
Q2 		$9.63M Sell
879,740
-765,308
-47% -$8.39M 0.56% 89
2017
Q1 		$17.4M Sell
1,645,048
-140,778
-8% -$1.36M 0.99% 40
2016
Q4 		$15M Buy
1,785,826
+235,820
+15% +$1.85M 0.88% 54
2016
Q3 		$11.1M Sell
1,550,006
-118,301
-7% -$823K 0.72% 74
2016
Q2 		$12.8M Sell
1,668,307
-128,662
-7% -$917K 0.8% 64
2016
Q1 		$13.1M Sell
1,796,969
-15,926
-0.9% -$114K 0.81% 68
2015
Q4 		$14M Buy
1,812,895
+339,282
+23% +$2.59M 0.8% 63
2015
Q3 		$10.5M Buy
1,473,613
+329,109
+29% +$3.16M 0.59% 87
2015
Q2 		$12.2M Buy
1,144,504
+187,923
+20% +$2.2M 0.63% 81
2015
Q1 		$11.8M Sell
956,581
-5,250
-0.5% -$58.1K 0.66% 62
2014
Q4 		$8.97M Buy
961,831
+171,543
+22% +$1.65M 0.49% 84
2014
Q3 		$7.92M Buy
+790,288
New +$8.04M 0.45% 93

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co's ELOS Position: Q3 2017 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 879,740 shares — an estimated $9.63M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in ELOS in Q3 2014 and held it in 12 quarters. The position peaked at $17.4M in Q1 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 879,740 Syneron Medical Ltd shares in Q3 2017, an estimated $9.63M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Syneron Medical Ltd in Q3 2014 and held it in 12 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Syneron Medical Ltd position peaked at $17.4M in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q3 2017, filed 12 Oct 2017.